Incannex Healthcare Inc. (IXHL)
About Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $12.0K
- Net income
- -$46.9M
- Total assets
- $20.4M
- Market cap
- $34.9M
- Operating margin
- -27661.6%
- Net margin
- -54517.4%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $86.0K
- Operating expenses
- $23.9M
- Operating income
- -$23.8M
- Net income
- -$46.9M
- EPS (basic)
- $-1.35
- EPS (diluted)
- $-1.35
Balance sheet
- Total assets
- $20.4M
- Current assets
- $20.0M
- Total liabilities
- $7.1M
- Current liabilities
- $7.0M
- Shareholders’ equity
- $13.4M
Cash flow
- Operating cash flow
- -$12.5M
- Investing cash flow
- -$8.0K
- Financing cash flow
- $21.4M
- Net cash flow
- $9.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $34.9M
- EPS (diluted)
- $-1.35
- Shares outstanding
- 11.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 25, 2022
Incannex Healthcare Inc. (IXHL) Stock Price
- Reported a net loss of $46.9M in FY2024.
- Revenue grew 617% from FY2024 to FY2025.
- Trading 94% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Incannex Healthcare Inc..
Write a review
News about Incannex Healthcare Inc.
News & sentiment via Polygon.io
Incannex Healthcare Inc.: frequently asked questions
Is Incannex Healthcare Inc. an American company?
Incannex Healthcare Inc. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Incannex Healthcare Inc. publicly traded?
Yes — Incannex Healthcare Inc. is a publicly traded company. Its stock trades under the ticker symbol IXHL on the NASDAQ.
What does Incannex Healthcare Inc. do?
Incannex Healthcare Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
